Skip to content

The Impact of Intraoperative Target Temperature Management on the Incidence of Postoperative Adverse Reactions in Elderly Patients Undergoing Gastrointestinal Surgery

The Impact of Intraoperative Target Temperature Management on the Incidence of Postoperative Adverse Reactions in Elderly Patients Undergoing Gastrointestinal Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102407
Enrollment
Unknown
Registered
2025-05-14
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative neurocognitive disorders (NCDs)

Interventions

Enhanced Warming Group :Maintain the intraoperative body temperature of the subjects within the range of 36.5?-37.5?.
Active Warming Group:Maintain the intraoperative body temperature of the subjects within the range of 36? to 36.5?.
Routine Warming Group:Maintain the intraoperative body temperature of the subjects at no less than 35.5?.

Sponsors

Affiliated Hospital of Yan'an University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients undergoing gastrointestinal malignant tumor resection under general anesthesia from January 2025 to January 2026. 2. Age >= 65 years. 3. American Society of Anesthesiologists (ASA) physical status classification of II or III. 4. Surgical duration of 2 to 4 hours. 5. Anticipated hospital stay exceeding 7 days.

Exclusion criteria

Exclusion criteria: 1. Obesity (Body Mass Index [BMI] >= 28 kg/m²); 2. Patients with preoperative core temperature higher than 38? or lower than 36?; 3. Abnormal coagulation function; 4. History of diseases that affect body temperature, such as ischemic heart disease, thyroid disease, cerebrovascular disease, Parkinson's disease, or Raynaud's syndrome; 5. Intraoperative body temperature too high (>38?) or too low (<34?), or recent infections with fever, thyroid dysfunction, or other diseases that affect body temperature; 6. Patients with dysfunction of important organs such as heart, liver, or kidney, endocrine or immune dysfunction, mental disorders, or a Mini-Mental State Examination (MMSE) score <15 points; 7. Those who refuse to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative delirium within 7 days after surgery;Delirium subtypes of postoperative delirium within 7 days after surgery;

Secondary

MeasureTime frame
Postoperative thermal comfort;Postoperative shivering intensity;Incidence of delayed neurocognitive recovery;Incidence of emergence delirium;Length of stay in post-anesthesia care unit (PACU);Proportion of patients requiring blood transfusion;Length of stay in hospital after surgery;Quality of recovery in the third postoperative day;Patient's body temperature upon exiting the PACU (Post-Anesthesia Care Unit);Infection rate within 7 days after surgery;

Countries

China

Contacts

Public ContactGao Hui/Jinyu Xu

Affiliated Hospital of Yan'an University

13399113091@163.com+86 133 9911 3091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026